Today: 23 June 2026
Browse Category

NASDAQ:PSYB 19 April 2026

Psyence Biomedical in Spotlight After Trump’s Ibogaine Order Puts Supply Strategy to the Test

Psyence Biomedical in Spotlight After Trump’s Ibogaine Order Puts Supply Strategy to the Test

Psyence Biomedical shares jumped 29.5% to $7.60 after President Trump signed an order to accelerate research into psychedelic drugs, including ibogaine. The order offers faster FDA handling and $50 million in federal support but does not legalize ibogaine. Psyence, which supplies GMP-grade ibogaine, has no approved products and its lead drug is still in Phase IIb trials.
19 April 2026
·

Stock Market Today

  • 2 Wide-Moat Bargain Stocks: Netflix and Microsoft Underpriced Amid Tech Sell-Off
    June 23, 2026, 1:58 AM EDT. In a market where valuation metrics like the S&P 500's price-to-earnings (P/E) ratio hit 27 and Nasdaq-100 trades at 34, Netflix and Microsoft stand out as undervalued wide-moat stocks. Netflix shares are down 41% from last year, trading at a P/E of 28 despite 16% revenue growth and strong operating margins of 32.3%. Its recent drop followed disappointing guidance and a failed Warner Bros. Discovery takeover bid. Microsoft, down roughly 33% since last October, faces AI competition concerns but continues solid performance. Both are trading near 18-month lows and offer attractive entry points given their competitive advantages and growth prospects.

Latest articles

Amazon Stock Just Got Hit Before Prime Day — AI Spending Fears Are Back

Amazon Stock Just Got Hit Before Prime Day — AI Spending Fears Are Back

23 June 2026
Amazon shares plunged 4.75% to $232.79 as investors questioned whether the company’s massive AI and cloud spending will pay off quickly enough, just ahead of Prime Day—a key test of U.S. consumer demand—with Bank of America projecting $21.6 billion in sales for the event and analysts warning that profit quality could disappoint if shoppers focus on lower-margin essentials.
Keel Shares Hit Record—What’s Next for the Stock

Keel Shares Hit Record—What’s Next for the Stock

23 June 2026
Keel Infrastructure Corp. surged 5.9% to a 52-week high as investors bet its power sites can be converted to AI data-center leases, with shares ending at $6.66 on heavy volume; the stock’s rally now hinges on permits, construction, and landing customer contracts, while upcoming Russell 3000 index inclusion and recent $458 million convertible note financing add both opportunity and dilution risk.
Go toTop